PCI 3.06.26
Media Pack
News

Current Edition

Issue 9, Volume 3

Current Features

Issue 9, Volume 3

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

AI in Drug Discovery
Auto Draft
Auto Draft
Elrig
Auto Draft
CPHI
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper
news

Former Editas CEO Bosley joins UK venture capital firm

Dive Brief: Katrine Bosley, the former CEO of gene editing biotech company Editas Medicine, has joined U.K.-based Advent Life Sciences as a venture partner, the in...
30 May 2022 news CEO | Editas
Continue Reading →
news

Seagen CEO Siegall resigns amid domestic violence investigation

One week after placing CEO Clay Siegall on leave, cancer drug developer Seagen announced Monday that its cofounder and longtime leader has resigned as he faces an all...
22 May 2022 news CEO | domestic
Continue Reading →
news

Vertex adds to Boston expansion with plans for new site

Dive Brief: Fresh off the dedication of a major new building in Boston’s Seaport, Vertex Pharmaceuticals said it’s making plans for yet another facility that it cl...
22 May 2022 news Biotech | Boston
Continue Reading →
news

Biogen CEO to step down as company pulls back from Alzheimer’s drug

Biogen is searching for a new CEO along with additional ways to cut costs after another quarter of paltry sales for its closely watched Alzheimer’s disease drug. Onc...
9 May 2022 news Alzheimer | Biogen
Continue Reading →
news

Adagio pledges to press forward with COVID drug as CEO to resign

Dive Brief: Adagio Therapeutics CEO Tillman Gerngross has agreed "in principle" to resign as head of the COVID-19 drug developer amid confusion over whether its mo...
24 February 2022 news Adagio | Adimab
Continue Reading →
news

Spark CEO Marrazzo, who led company to historic gene therapy approval, to step down

Jeffrey Marrazzo, CEO of gene therapy developer Spark Therapeutics, will step down as head of the company he co-founded almost nine years ago, steered to a historic F...
24 February 2022 news approval | CEO
Continue Reading →
news

Saunders: All options remain on the table for Allergan

Brief: Allergan CEO Brent Saunders said Monday the Irish pharma is considering a wide range of business options, including further divestitures or a split of the ...
1 May 2018 news Allergan | CEO
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook
Bio Pharmaceutical Media © 2026, All Rights Reserved – Powered by Teksyte